Related Experiment Video

Updated: Jun 8, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

RNAi-mediated CD73 suppression induces apoptosis and cell-cycle arrest in human breast cancer cells

Xiuling Zhi1, Yingjian Wang, Xuerui Zhou

  • 1Department of Physiology and Pathophysiology, Shanghai Medical College, Shanghai, China.

Cancer Science
|September 30, 2010
PubMed

Insights

Ecto-5'-nucleotidase (CD73) overexpression promotes breast cancer growth by enhancing cell viability and progression. Suppressing CD73 inhibits tumor growth and increases apoptosis, highlighting its role in cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Ecto-5'-nucleotidase (CD73) is a cell surface enzyme that hydrolyzes AMP to adenosine.
  • CD73 is frequently overexpressed in various solid tumors, suggesting a role in cancer progression.

Purpose of the Study:

  • To investigate the role of CD73 in breast cancer progression.
  • To determine the effects of CD73 suppression and overexpression on tumor growth, cell cycle, and apoptosis.

Main Methods:

  • RNA interference (siRNA) to suppress CD73 expression.
  • In vivo and in vitro tumor growth assays (whole-body imaging, clone formation, TUNEL assay).
  • Flow cytometry for cell cycle analysis and Western blotting for apoptosis-related proteins (Bcl-2, Bax, caspase-3).
  • Enzyme activity assays and CD73 inhibitor (APCP) treatment.

Main Results:

  • CD73 suppression significantly reduced tumor growth in vivo and in vitro.
  • CD73 suppression led to G0/G1 cell cycle arrest and increased late apoptosis.
  • Downregulation of Bcl-2 and upregulation of Bax and caspase-3 were observed upon CD73 suppression.
  • CD73 overexpression enhanced cell viability, promoted cell cycle progression, and induced a tumorigenic phenotype in breast cancer cells.
  • The CD73 inhibitor APCP mimicked the effects of RNAi-mediated CD73 suppression.

Conclusions:

  • CD73 plays a critical role in promoting breast cancer growth.
  • CD73 influences breast cancer progression by regulating cell cycle progression and apoptosis.
  • Targeting CD73 may represent a potential therapeutic strategy for breast cancer.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...